ERBB2 and breast carcinoma: Reactivation of additional p110 isoforms such as p110β has also been shown to sustain PIP3 accumulation and attenuate the growth inhibitory effect induced by p110α inhibition in PIK3CA-mutant and HER2-amplified breast cancer cells [123].